These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 22833470

  • 1. PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation.
    Hagiwara K, Ito H, Murate T, Miyata Y, Ohashi H, Nagai H.
    Genes Chromosomes Cancer; 2012 Nov; 51(11):1024-36. PubMed ID: 22833470
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.
    Versmold B, Felsberg J, Mikeska T, Ehrentraut D, Köhler J, Hampl JA, Röhn G, Niederacher D, Betz B, Hellmich M, Pietsch T, Schmutzler RK, Waha A.
    Int J Cancer; 2007 Aug 01; 121(3):547-54. PubMed ID: 17415710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The promoter activity of human Mfn2 depends on Sp1 in vascular smooth muscle cells.
    Sorianello E, Soriano FX, Fernández-Pascual S, Sancho A, Naon D, Vila-Caballer M, González-Navarro H, Portugal J, Andrés V, Palacín M, Zorzano A.
    Cardiovasc Res; 2012 Apr 01; 94(1):38-47. PubMed ID: 22253285
    [Abstract] [Full Text] [Related]

  • 8. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
    Liang H, O'Reilly S, Liu Y, Abounader R, Laterra J, Maher VM, McCormick JJ.
    Int J Oncol; 2004 May 01; 24(5):1057-67. PubMed ID: 15067326
    [Abstract] [Full Text] [Related]

  • 9. Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies.
    Nagai H, Li Y, Hatano S, Toshihito O, Yuge M, Ito E, Utsumi M, Saito H, Kinoshita T.
    Genes Chromosomes Cancer; 2003 Sep 01; 38(1):13-21. PubMed ID: 12874782
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineage.
    Yu SJ, Zheng L, Ladanyi M, Asa SL, Ezzat S.
    Clin Cancer Res; 2004 Oct 01; 10(19):6750-8. PubMed ID: 15475466
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells.
    Hantusch B, Kalt R, Krieger S, Puri C, Kerjaschki D.
    BMC Mol Biol; 2007 Mar 07; 8():20. PubMed ID: 17343736
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
    Hamada T, Goto M, Tsutsumida H, Nomoto M, Higashi M, Sugai T, Nakamura S, Yonezawa S.
    Cancer Lett; 2005 Sep 28; 227(2):175-84. PubMed ID: 16112420
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
    Laryngoscope; 2005 Aug 28; 115(8):1395-401. PubMed ID: 16094112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.